Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2008

01-10-2008 | Original Paper

Racial Differences in Disease Extent and Severity in Patients with Ulcerative Colitis: A Retrospective Cohort Study

Authors: Mark H. Flasar, Sandra Quezada, Priti Bijpuria, Raymond K. Cross

Published in: Digestive Diseases and Sciences | Issue 10/2008

Login to get access

Abstract

Introduction Ulcerative colitis (UC) is increasing in African-Americans (AA). The objectives of this study were to assess disease extent and severity in UC by race. Methods Disease extent and severity was assessed in UC outpatients evaluated at the University of Maryland and Baltimore VA from 1997 to 2005. Results About 197 patients were identified; 47 were AA (23%). Of AA, 23% had proctitis, 23% had left-sided colitis, and 53% had extensive colitis compared to 10%, 31%, and 59% of Caucasians, respectively (P = 0.056). African-Americans were less likely to ever receive steroids (45% versus 62%; P = 0.065), be treated with ≥2 courses of steroids (54% versus 68%; P = 0.242) or be steroid dependant (33% versus 46%; P = 0.304). After adjustment, only female gender (OR 0.32, [0.16–0.66]) and age at diagnosis (OR 2.50, [1.28–4.90]) were associated with extensive colitis. Being seen at UMMS (OR 5.10, [2.60–10.10]) was associated with steroid use. Conclusion Race was not associated with extent of colitis or disease severity in UC.
Literature
1.
go back to reference Mendeloff AI, Monk M, Siegel CI et al (1966) Some epidemiological features of ulcerative colitis and regional enteritis. A preliminary report. Gastroenterology 51(5):748–756PubMed Mendeloff AI, Monk M, Siegel CI et al (1966) Some epidemiological features of ulcerative colitis and regional enteritis. A preliminary report. Gastroenterology 51(5):748–756PubMed
2.
go back to reference Rogers BH, Clark LM, Kirsner JB (1971) The epidemiologic and demographic characteristics of inflammatory bowel disease: an analysis of a computerized file of 1400 patients. J Chronic Dis 24(12):743–773PubMedCrossRef Rogers BH, Clark LM, Kirsner JB (1971) The epidemiologic and demographic characteristics of inflammatory bowel disease: an analysis of a computerized file of 1400 patients. J Chronic Dis 24(12):743–773PubMedCrossRef
3.
go back to reference Calkins BM, Lilienfeld AM, Garland CF et al (1984) Trends in incidence rates of ulcerative colitis and Crohn’s disease. Dig Dis Sci 29(10):913–920PubMedCrossRef Calkins BM, Lilienfeld AM, Garland CF et al (1984) Trends in incidence rates of ulcerative colitis and Crohn’s disease. Dig Dis Sci 29(10):913–920PubMedCrossRef
4.
go back to reference Pinchbeck BR, Kirdeikis J, Thomson AB (1988) Inflammatory bowel disease in northern Alberta. An epidemiologic study. J Clin Gastroenterol 10(5):505–515PubMedCrossRef Pinchbeck BR, Kirdeikis J, Thomson AB (1988) Inflammatory bowel disease in northern Alberta. An epidemiologic study. J Clin Gastroenterol 10(5):505–515PubMedCrossRef
5.
go back to reference Hiatt RA, Kaufman L (1988) Epidemiology of inflammatory bowel disease in a defined northern California population. West J Med 149(5):541–546PubMed Hiatt RA, Kaufman L (1988) Epidemiology of inflammatory bowel disease in a defined northern California population. West J Med 149(5):541–546PubMed
6.
go back to reference Stowe SP, Redmond SR, Stormont JM et al (1990) An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology 98(1):104–110PubMed Stowe SP, Redmond SR, Stormont JM et al (1990) An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology 98(1):104–110PubMed
7.
go back to reference Loftus EV Jr., Silverstein MD, Sandborn WJ et al (2000) Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gut 46(3):336–343PubMedCrossRef Loftus EV Jr., Silverstein MD, Sandborn WJ et al (2000) Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gut 46(3):336–343PubMedCrossRef
8.
go back to reference Bernstein CN, Blanchard JF, Rawsthorne P et al (1999) Epidemiology of Crohn’s disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 149(10):916–924PubMed Bernstein CN, Blanchard JF, Rawsthorne P et al (1999) Epidemiology of Crohn’s disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 149(10):916–924PubMed
9.
go back to reference Blanchard JF, Bernstein CN, Wajda A et al (2001) Small-area variations and sociodemographic correlates for the incidence of Crohn’s disease and ulcerative colitis. Am J Epidemiol 154(4):328–335PubMedCrossRef Blanchard JF, Bernstein CN, Wajda A et al (2001) Small-area variations and sociodemographic correlates for the incidence of Crohn’s disease and ulcerative colitis. Am J Epidemiol 154(4):328–335PubMedCrossRef
10.
go back to reference Ogunbi SO, Ransom JA, Sullivan K et al (1998) Inflammatory bowel disease in African-American children living in Georgia. J Pediatr 133(1):103–107PubMedCrossRef Ogunbi SO, Ransom JA, Sullivan K et al (1998) Inflammatory bowel disease in African-American children living in Georgia. J Pediatr 133(1):103–107PubMedCrossRef
11.
go back to reference Sonnenberg A, McCarty DJ, Jacobsen SJ (1991) Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 100(1):143–149PubMed Sonnenberg A, McCarty DJ, Jacobsen SJ (1991) Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 100(1):143–149PubMed
12.
go back to reference Sonnenberg A, Wasserman IH (1991) Epidemiology of inflammatory bowel disease among U.S. military veterans. Gastroenterology 101(1):122–130PubMed Sonnenberg A, Wasserman IH (1991) Epidemiology of inflammatory bowel disease among U.S. military veterans. Gastroenterology 101(1):122–130PubMed
13.
go back to reference Basu D, Lopez I, Kulkarni A et al (2005) Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol 100(10):2254–2261PubMedCrossRef Basu D, Lopez I, Kulkarni A et al (2005) Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol 100(10):2254–2261PubMedCrossRef
14.
go back to reference Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2–6; discussion 16–9PubMedCrossRef Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2–6; discussion 16–9PubMedCrossRef
15.
go back to reference Picco MF, Krishna M, Cangemi JR et al (2006) Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis. Inflamm Bowel Dis 12(7):537–542PubMedCrossRef Picco MF, Krishna M, Cangemi JR et al (2006) Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis. Inflamm Bowel Dis 12(7):537–542PubMedCrossRef
16.
go back to reference Satsangi J, Silverberg MS, Vermeire S et al (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55(6):749–753PubMedCrossRef Satsangi J, Silverberg MS, Vermeire S et al (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55(6):749–753PubMedCrossRef
17.
go back to reference Lichtenstein GR, Abreu MT, Cohen R et al (2006) American gastroenterological association institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology 130(3):940–987PubMedCrossRef Lichtenstein GR, Abreu MT, Cohen R et al (2006) American gastroenterological association institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology 130(3):940–987PubMedCrossRef
18.
go back to reference Nguyen GC, Torres EA, Regueiro M et al (2006) Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol 101(5):1012–1023PubMedCrossRef Nguyen GC, Torres EA, Regueiro M et al (2006) Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol 101(5):1012–1023PubMedCrossRef
19.
go back to reference Meucci G, Vecchi M, Astegiano M et al (2000) The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Am J Gastroenterol 95(2):469–473PubMedCrossRef Meucci G, Vecchi M, Astegiano M et al (2000) The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Am J Gastroenterol 95(2):469–473PubMedCrossRef
20.
go back to reference Moum B, Ekbom A, Vatn MH et al (1999) Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time. Am J Gastroenterol 94(6):1564–1569PubMedCrossRef Moum B, Ekbom A, Vatn MH et al (1999) Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time. Am J Gastroenterol 94(6):1564–1569PubMedCrossRef
21.
go back to reference Nguyen GC, Laveist TA, Gearhart S et al (2006) Racial and geographic variations in colectomy rates among hospitalized ulcerative colitis patients. Clin Gastroenterol Hepatol 4(12):1507–1513PubMedCrossRef Nguyen GC, Laveist TA, Gearhart S et al (2006) Racial and geographic variations in colectomy rates among hospitalized ulcerative colitis patients. Clin Gastroenterol Hepatol 4(12):1507–1513PubMedCrossRef
22.
go back to reference Langholz E, Munkholm P, Davidsen M et al (1996) Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol 31(3):260–266PubMedCrossRef Langholz E, Munkholm P, Davidsen M et al (1996) Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol 31(3):260–266PubMedCrossRef
23.
go back to reference Schroeder KW, Tremaine WJ, Ilstrup DM (1987) Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 317(26):1625–1629PubMedCrossRef Schroeder KW, Tremaine WJ, Ilstrup DM (1987) Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 317(26):1625–1629PubMedCrossRef
24.
go back to reference Sutherland LR, Martin F, Greer S et al (1987) 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 92(6):1894–1898PubMed Sutherland LR, Martin F, Greer S et al (1987) 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 92(6):1894–1898PubMed
25.
go back to reference Powell-Tuck J, Day DW, Buckell NA et al (1982) Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci 27(6):533–537PubMedCrossRef Powell-Tuck J, Day DW, Buckell NA et al (1982) Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci 27(6):533–537PubMedCrossRef
26.
go back to reference Walmsley RS, Ayres RC, Pounder RE et al (1998) A simple clinical colitis activity index. Gut 43(1):29–32PubMedCrossRef Walmsley RS, Ayres RC, Pounder RE et al (1998) A simple clinical colitis activity index. Gut 43(1):29–32PubMedCrossRef
27.
go back to reference Higgins PD, Schwartz M, Mapili J et al (2005) Is endoscopy necessary for the measurement of disease activity in ulcerative colitis? Am J Gastroenterol 100(2):355–361PubMedCrossRef Higgins PD, Schwartz M, Mapili J et al (2005) Is endoscopy necessary for the measurement of disease activity in ulcerative colitis? Am J Gastroenterol 100(2):355–361PubMedCrossRef
28.
go back to reference Faubion WA Jr, Loftus EV Jr, Harmsen WS et al (2001) The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 121(2):255–260PubMedCrossRef Faubion WA Jr, Loftus EV Jr, Harmsen WS et al (2001) The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 121(2):255–260PubMedCrossRef
29.
go back to reference Hommes DBF, van Assche G, Caenepeel F, Vergauwe P (2006) The ideal management of Crohn’s disease: top-down versus step-up strategies, a randomized controlled trial. Gastroenterology 130:A-108 Hommes DBF, van Assche G, Caenepeel F, Vergauwe P (2006) The ideal management of Crohn’s disease: top-down versus step-up strategies, a randomized controlled trial. Gastroenterology 130:A-108
Metadata
Title
Racial Differences in Disease Extent and Severity in Patients with Ulcerative Colitis: A Retrospective Cohort Study
Authors
Mark H. Flasar
Sandra Quezada
Priti Bijpuria
Raymond K. Cross
Publication date
01-10-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-0190-x

Other articles of this Issue 10/2008

Digestive Diseases and Sciences 10/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.